Back to top
more

Agenus (AGEN)

(Delayed Data from NSDQ)

$5.40 USD

5.40
1,525,567

-0.90 (-14.29%)

Updated Apr 17, 2024 04:00 PM ET

After-Market: $5.40 0.00 (0.00%) 7:58 PM ET

Zacks Rank:

This is our short term rating system that serves as a timeliness indicator for stocks over the next 1 to 3 months. How good is it? See rankings and related performance below.

Zacks Rank Definition Annualized Return
1Strong Buy24.15%
2Buy18.00%
3Hold9.44%
4Sell5.10%
5Strong Sell2.53%
S&P50011.08%

Zacks Rank Education - Learn about the Zacks Rank

Zacks Rank Home - Zacks Rank resources in one place

Zacks Premium - The only way to fully access the Zacks Rank

3-Hold of 5     3    

Style Scores:

The Style Scores are a complementary set of indicators to use alongside the Zacks Rank. It allows the user to better focus on the stocks that are the best fit for his or her personal trading style.

The scores are based on the trading styles of Value, Growth, and Momentum. There's also a VGM Score ('V' for Value, 'G' for Growth and 'M' for Momentum), which combines the weighted average of the individual style scores into one score.

Value Score A
Growth Score A
Momentum Score A
VGM Score A

Within each Score, stocks are graded into five groups: A, B, C, D and F. As you might remember from your school days, an A, is better than a B; a B is better than a C; a C is better than a D; and a D is better than an F.

As an investor, you want to buy stocks with the highest probability of success. That means you want to buy stocks with a Zacks Rank #1 or #2, Strong Buy or Buy, which also has a Score of an A or a B in your personal trading style.

Zacks Style Scores Education - Learn more about the Zacks Style Scores

F Value C Growth A Momentum D VGM

Industry Rank:

The Zacks Industry Rank assigns a rating to each of the 265 X (Expanded) Industries based on their average Zacks Rank.

An industry with a larger percentage of Zacks Rank #1's and #2's will have a better average Zacks Rank than one with a larger percentage of Zacks Rank #4's and #5's.

The industry with the best average Zacks Rank would be considered the top industry (1 out of 265), which would place it in the top 1% of Zacks Ranked Industries. The industry with the worst average Zacks Rank (265 out of 265) would place in the bottom 1%.

Zacks Rank Education -- Learn more about the Zacks Rank
Zacks Industry Rank Education -- Learn more about the Zacks Industry Rank

Top 33% (82 out of 251)

Industry: Medical - Biomedical and Genetics

Zacks Premium FeatureView All Zacks #1 Ranked Stocks

Better trading starts here.

Balance Sheet

Research for AGEN

The Zacks Equity Research reports, or ZER for short, are our in-house, independently produced research reports.

The ever popular one-page Snapshot reports are generated for virtually every single Zacks Ranked stock. It's packed with all of the company's key stats and salient decision making information. Including the Zacks Rank, Zacks Industry Rank, Style Scores, the Price, Consensus & Surprise chart, graphical estimate analysis and how a stocks stacks up to its peers.

The detailed multi-page Analyst report does an even deeper dive on the company's vital statistics. In addition to all of the proprietary analysis in the Snapshot, the report also visually displays the four components of the Zacks Rank (Agreement, Magnitude, Upside and Surprise); provides a comprehensive overview of the company business drivers, complete with earnings and sales charts; a recap of their last earnings report; and a bulleted list of reasons to buy or sell the stock. It also includes an industry comparison table to see how your stock compares to its expanded industry, and the S&P 500.

Researching stocks has never been so easy or insightful as with the ZER Analyst and Snapshot reports.

Learn more about Zacks Equity Research reports

See more Zacks Equity Research reports

 

Fiscal Year End for Agenus Inc falls in the month of December.

All items in Millions except Per Share data.

12/31/2023 12/31/2022 12/31/2021 12/31/2020 12/31/2019
Assets          
Cash & Equivalents 76 193 307 100 62
Receivables 26 3 2 1 16
Notes Receivable 0 0 0 0 0
Inventories 0 0 0 0 0
Other Current Assets 10 17 24 13 8
Total Current Assets 112 213 332 114 87
Net Property & Equipment 133 133 60 27 26
Investments & Advances 0 0 0 0 0
Other Non-Current Assets 0 0 0 0 0
Deferred Charges 0 0 0 0 0
Intangibles 29 32 33 36 34
Deposits & Other Assets 9 4 10 4 1
Total Assets 314 414 466 215 155
Liabilities & Shareholders Equity 12/31/2023 12/31/2022 12/31/2021 12/31/2020 12/31/2019
Notes Payable 0 0 0 0 0
Accounts Payable 61 41 30 17 14
Current Portion Long-Term Debt 0 1 1 1 1
Current Portion Capital Leases 0 0 0 0 0
Accrued Expenses 45 38 42 29 31
Income Taxes Payable 0 0 0 0 0
Other Current Liabilities 146 107 81 81 75
Total Current Liabilities 256 189 157 130 122
Mortgages 0 0 0 0 0
Deferred Taxes/Income 1 1 11 28 28
Convertible Debt 0 0 0 0 0
Long-Term Debt 13 13 13 19 13
Non-Current Capital Leases 0 0 0 0 0
Other Non-Current Liabilities 130 202 195 188 188
Minority Interest (Liabilities) 0 0 0 27 27
Total Liabilities 462 468 418 426 387
Shareholders Equity 12/31/2023 12/31/2022 12/31/2021 12/31/2020 12/31/2019
Preferred Stock 0 0 0 0 0
Common Stock (Par) 4 3 3 2 1
Capital Surplus 1,792 1,645 1,520 1,258 1,060
Retained Earnings -1,956 -1,710 -1,490 -1,466 -1,285
Other Equity 11 7 15 -5 -7
Treasury Stock 0 0 0 0 0
Total Shareholder's Equity -148 -55 48 -212 -231
Total Liabilities & Shareholder's Equity 314 414 466 215 155
Total Common Equity -148 -55 48 -212 -231
Shares Outstanding 19.00 15.20 12.80 9.50 6.80
Book Value Per Share -7.81 -3.61 3.74 -22.26 -34.02

Fiscal Year End for Agenus Inc falls in the month of December.

All items in Millions except Per Share data.

3/31/2024 12/31/2023 9/30/2023 6/30/2023 3/31/2023
Assets          
Cash & Equivalents -99,999 76 106 158 189
Receivables NA 26 1 1 1
Notes Receivable NA 0 0 0 0
Inventories NA 0 0 0 0
Other Current Assets NA 10 18 12 15
Total Current Assets NA 112 126 171 206
Net Property & Equipment NA 133 140 143 140
Investments & Advances NA 0 0 0 0
Other Non-Current Assets NA 0 0 0 0
Deferred Charges NA 0 0 0 0
Intangibles NA 29 29 30 31
Deposits & Other Assets NA 9 11 9 4
Total Assets NA 314 335 384 413
Liabilities & Shareholders Equity 3/31/2024 12/31/2023 9/30/2023 6/30/2023 3/31/2023
Notes Payable NA 0 0 0 0
Accounts Payable NA 61 41 52 47
Current Portion Long-Term Debt NA 0 0 1 1
Current Portion Capital Leases NA 0 0 0 0
Accrued Expenses NA 45 38 30 33
Income Taxes Payable NA 0 0 0 0
Other Current Liabilities NA 146 117 119 108
Total Current Liabilities NA 256 198 204 191
Mortgages NA 0 0 0 0
Deferred Taxes/Income NA 1 1 1 1
Convertible Debt NA 0 0 0 0
Long-Term Debt NA 13 13 13 13
Non-Current Capital Leases NA 0 0 0 0
Other Non-Current Liabilities NA 175 180 198
Minority Interest (Liabilities) NA 0 0 0 0
Total Liabilities NA 462 451 460 466
Shareholders Equity 3/31/2024 12/31/2023 9/30/2023 6/30/2023 3/31/2023
Preferred Stock NA 0 0 0 0
Common Stock (Par) NA 4 4 4 3
Capital Surplus NA 1,792 1,777 1,751 1,715
Retained Earnings NA -1,956 -1,909 -1,847 -1,778
Other Equity NA 11 13 16 6
Treasury Stock NA 0 0 0 0
Total Shareholder's Equity NA -148 -115 -77 -53
Total Liabilities & Shareholder's Equity NA 314 335 384 413
Total Common Equity 0 -148 -115 -77 -53
Shares Outstanding 20.90 19.00 18.90 17.40 16.60
Book Value Per Share 0.00 -7.81 -6.10 -4.41 -3.20